Articles

Podcasts

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Data show among patients with focal FDG uptake, PET/MRI and inflammatory blood markers resolved at follow-up performed at a mean of 52 days after baseline. 

Myocardial Inflammation After COVID-19 Improves Over Short-Term Follow-Up 

Data show the 1-year incidence of the composite primary endpoint was 10.6% among patients randomized to FFR-guided PCI and 6.9% in CABG. 

FFR-Guided PCI Not Shown to Be Noninferior to CABG in Patients with Three-Vessel CAD 

Sexual activity was involved in 0.2% of all SCDs, with sudden arrhythmic death syndrome and cardiomyopathies predominant underlying causes. 

Sexual Activity Shows Low Association With Sudden Cardiac Death in Younger Patients

Abbott's device is designed to create highly detailed 3-dimensional maps of the heart to help physicians identify and treat abnormal rhythms. 

FDA Grants Clearance To Cardiac Mapping System For Cardiac Arrhythmia Treatment 

Data show Black and White patients had a similar risk of MACE over a median 24.4-month follow-up. 

Low Prevalence of Epicardial CAD Observed in Black Patients Despite Higher CV Risk 

From the pooled results of TRILOGY 1 and 2, data show 4 g/d of ω-3–PL/FFA reduced TG levels by 10.9% at 12 weeks and 12.7% at 26 weeks, relative to placebo. 

Novel ω-3 Formulation Reduced Triglyceride Levels in Severe Hypertriglyceridemia

The treatment reduces the amount of LDL-C in the bloodstream by improving the liver’s ability to prevent protein production, which plays a role in keeping circulating cholesterol levels high. 

FDA Approves LDL Cholesterol Lowering Inclisiran Injections

Cardiologists have utilized new technologies during the COVID-19 pandemic.

Wearables Take On New Meaning in Cardiovascular Care

Study data show for each $1,000 decrease in median household income, the number of TAVR procedures performed per 100,000 Medicare beneficiaries was 0.2% lower.

Low Socioeconomic Status Linked to Lower Rates of TAVR in Aortic Stenosis Treatment 

The treatment was effective across all weight groups.

Lawrence A. Leiter, MD: Inclisiran Lower Cholesterol in Overweight Individuals

Lipid Management condition center page, resources on the topics of medical news and expert insight into lipidology can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dyslipidemia research, treatment, and drug development.